premise: The FDA examined the final rule as prescribed by the Act and found that no mandate will be imposed on State, local or tribal governments and it believes that the burden on the private sector will be below the $100 million annual expenditure level to require compliance with the Act.
hypothesis: The burden of the private sector will be below $100 million.